| |
|
|
|
Ocular Therapeutix Inc.  
|
|
6.62 0.16 (0.03%) |
09-25 16:00 |
|
Open: |
6.46 |
Pre close: |
6.44 |
Target:
|
8.22 
|
|
High: |
6.7 |
Low: |
6.46 |
Resistance:
|
7.04
8.22
|
|
Volume: |
542,711 |
Market Cap: |
255M |
Support:
|
6.38
5.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.47
|
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
6.54 |
Signal(12,26,9): |
0.05  |
|
MA(100): |
6.61 |
Stochastic Oscillator |
%K(14,3):
|
41.67 |
|
MA(250): |
5.97 |
%D(3): |
36.96 |
|
Average Volume(K) |
3-Month: |
37552
|
52-Week |
High:
|
8.28 |
|
10-Days: |
34617 |
Low: |
3.30 |
|
RSI |
RSI(14):
|
56.29 |
Change(%): |
3.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.750 |
Return on Equity (ttm) |
-118.6 |
Shares Out. (M) |
38.59 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-74.0 |
Shares Float (M) |
37.42 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
47.9 |
% Held by Institutions |
44.50 |
|
Forward EPS |
-1.381 |
Gross Profit (p.s.) |
0.010 |
Shares Short (K) |
4305 |
|
Book Value (p.s.) |
5.430 |
EBITDA (p.s.) |
-0.378 |
P/E |
-3.78 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.22 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-49.47 |
P/S |
4257763328.00 |
|
Operating Margin |
-2623.87 |
Levered Free Cash Flow
(M) |
-32.07 |
P/CF |
-5.16 |
|
|
|
|
|
|
